KR880002844A - 펜옥사지논, 이의 제조방법 및 용도 - Google Patents

펜옥사지논, 이의 제조방법 및 용도 Download PDF

Info

Publication number
KR880002844A
KR880002844A KR870009376A KR870009376A KR880002844A KR 880002844 A KR880002844 A KR 880002844A KR 870009376 A KR870009376 A KR 870009376A KR 870009376 A KR870009376 A KR 870009376A KR 880002844 A KR880002844 A KR 880002844A
Authority
KR
South Korea
Prior art keywords
hydrogen
dsm
compound
hydroxyl
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR870009376A
Other languages
English (en)
Korean (ko)
Inventor
제엑 악첼
브라이딩-막 사비네
그라블러이 주자네
보엘스코브 하르트무트
자이베르트 게르하르트
Original Assignee
하인리히 벡커, 베른하르트 벡
훽스트 아크티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 하인리히 벡커, 베른하르트 벡, 훽스트 아크티엔게젤샤프트 filed Critical 하인리히 벡커, 베른하르트 벡
Publication of KR880002844A publication Critical patent/KR880002844A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/38—[b, e]-condensed with two six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14—Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
KR870009376A 1986-08-27 1987-08-27 펜옥사지논, 이의 제조방법 및 용도 Ceased KR880002844A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3629062 1986-08-27
DEP3629062.9 1986-08-27

Publications (1)

Publication Number Publication Date
KR880002844A true KR880002844A (ko) 1988-05-11

Family

ID=6308253

Family Applications (1)

Application Number Title Priority Date Filing Date
KR870009376A Ceased KR880002844A (ko) 1986-08-27 1987-08-27 펜옥사지논, 이의 제조방법 및 용도

Country Status (14)

Country Link
US (1) US4861775A (enExample)
EP (1) EP0260486B1 (enExample)
JP (1) JPS6371190A (enExample)
KR (1) KR880002844A (enExample)
AT (1) ATE60326T1 (enExample)
AU (1) AU611642B2 (enExample)
DE (1) DE3767621D1 (enExample)
DK (1) DK446087A (enExample)
ES (1) ES2031860T3 (enExample)
GR (1) GR3001560T3 (enExample)
HU (1) HU201354B (enExample)
IL (1) IL83646A0 (enExample)
IN (1) IN164557B (enExample)
ZA (1) ZA876353B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03161441A (ja) * 1989-11-20 1991-07-11 Senjiyu Seiyaku Kk メイラード反応阻害剤
CN101132796A (zh) * 2005-02-17 2008-02-27 独立行政法人科学技术振兴机构 含有吩嗪化合物作为活性成分的药物组合物
CN118955425B (zh) * 2024-07-31 2026-01-16 首都医科大学附属北京胸科医院 一种酚噁嗪类化合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4667032A (en) * 1983-01-21 1987-05-19 Merck Frosst Canada, Inc. Phenothiazone derivatives and analogs

Also Published As

Publication number Publication date
EP0260486A1 (de) 1988-03-23
ES2031860T3 (es) 1993-01-01
IL83646A0 (en) 1988-01-31
AU611642B2 (en) 1991-06-20
DE3767621D1 (de) 1991-02-28
DK446087A (da) 1988-02-28
ZA876353B (en) 1988-03-01
ATE60326T1 (de) 1991-02-15
EP0260486B1 (de) 1991-01-23
IN164557B (enExample) 1989-04-08
AU7744187A (en) 1988-03-31
HUT44624A (en) 1988-03-28
US4861775A (en) 1989-08-29
HU201354B (en) 1990-10-28
JPS6371190A (ja) 1988-03-31
DK446087D0 (da) 1987-08-26
GR3001560T3 (en) 1992-11-23

Similar Documents

Publication Publication Date Title
DE69025336D1 (de) Antihypertensive Zubereitungen und deren Verwendung
NL168509C (nl) Werkwijze ter bereiding van een therapeutisch preparaat, alsmede werkwijze ter bereiding van daarvoor geschikte verbindingen.
JPS50148357A (enExample)
KR940007022A (ko) 피패리딘 유도체, 이것의 제법 및 치료에 있어서 이것의 이용
ATE4167T1 (de) Derivate der c-076-verbindungen.
FI822543A0 (fi) Pyrrolidinderivat
KR910016915A (ko) 과콜레스테롤혈증 치료제
KR940005274A (ko) 쇼그렌(Sjoegren)증후군 치료제
KR840007257A (ko) 레베카마이신과 그것의 제조방법
SE8107273L (sv) 2-oxoazetidinderivat, sett att framstella democh anvendning derav
ATE16190T1 (de) Derivate von c-076 verbindungen, deren herstellung und benuetzung, und sie enthaltende zusammensetzungen.
KR890009962A (ko) 매뉴마이신 유도체, 이의 제조방법 및 용도
JPS5592387A (en) Antibiotic substance tm-531
KR920018215A (ko) 류스트로덕신(leustroducsins)으로 명명된 신규 화합물, 그의 제조방법 및 그의 치료학적 용도
KR880002844A (ko) 펜옥사지논, 이의 제조방법 및 용도
KR900003177A (ko) 테트라시클릭계 우울증 치료제
KR890008136A (ko) 항균성 9-데옥소-9a-알릴 및 프로파길-9a-아자-9a-호모에리트로 마이신 A 유도체
KR880013927A (ko) 피리미딘 유도체
ES2194320T3 (es) Sustancias naturales antivirales o antitumorales y uso de las mismas.
KR890003755A (ko) 7- (2- 메틸- 4- 아미노피롤리디닐)나프티리딘 및 퀴놀린 화합물
KR890013019A (ko) 과뇨산혈증을 치료하는데 있어서의 옥소퀴나졸린 유도체의 용도
KR880002998A (ko) 가금류의 대장균증 백신
KR890003734A (ko) 신규한 nf-1616-904의 피라진옥사이드 화합물 및 이를 함유하는 약학 조성물
KR890017363A (ko) 스트로빌루린 유도체, 이들의 제법 및 용도
Shōji Study on Orientomycin, Identified With D-4-Amino-3-Isoxazolidone Studies on Actinomyces Antibiotics. XXXVII

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19870827

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19920522

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19870827

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19941124

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19950207

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19941124

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I